IMPORTANCE OF METABOLITES IN ANTI-ARRHYTHMIC THERAPY

被引:17
作者
WOOSLEY, RL
RODEN, DM
机构
关键词
D O I
10.1016/0002-9149(83)90625-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:C3 / C7
页数:5
相关论文
共 38 条
[1]  
BLUMER J, 1973, J PHARMACOL EXP THER, V186, P31
[2]  
CAREY EL, J CLIN INVEST
[3]  
COLLINSWORTH KA, 1975, CLIN PHARMACOL THER, V18, P59
[4]   SOME CELLULAR + METABOLIC CONSIDERATIONS RELATING TO ACTION OF QUINIDINE AS PROTOTYPE ANTIARRHYTHMIC AGENT [J].
CONN, HL ;
LUCHI, RJ .
AMERICAN JOURNAL OF MEDICINE, 1964, 37 (05) :685-+
[5]   QUANTITATIVE DETERMINATION OF QUINIDINE IN PLASMA [J].
CRAMER, G ;
ISAKSSON, B .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1963, 15 (05) :553-&
[6]  
DRAYER DE, 1981, CLIN CHEM, V27, P308
[7]  
DRAYER DE, 1977, J LAB CLIN MED, V90, P816
[8]  
DRAYER DE, 1977, CLIN PHARMACOL THER, V22, P63
[9]  
DRAYER DE, 1978, CLIN PHARMACOL THER, V24, P31
[10]   PHARMACOLOGICALLY ACTIVE DRUG METABOLITES - THERAPEUTIC AND TOXIC ACTIVITIES, PLASMA AND URINE DATA IN MAN, ACCUMULATION IN RENAL-FAILURE [J].
DRAYER, DE .
CLINICAL PHARMACOKINETICS, 1976, 1 (06) :426-443